Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

BUY
$20.34 - $23.73 $290,902 - $339,386
14,302 Added 5.39%
279,654 $6.28 Million
Q1 2024

May 03, 2024

SELL
$20.17 - $23.93 $66,298 - $78,657
-3,287 Reduced 1.22%
265,352 $6.3 Million
Q4 2023

Feb 08, 2024

SELL
$19.25 - $24.13 $33,860 - $42,444
-1,759 Reduced 0.65%
268,639 $6.44 Million
Q3 2023

Nov 09, 2023

SELL
$19.04 - $22.74 $310,751 - $371,139
-16,321 Reduced 5.69%
270,398 $5.91 Million
Q2 2023

Aug 07, 2023

SELL
$18.17 - $20.48 $71,280 - $80,343
-3,923 Reduced 1.35%
286,719 $5.48 Million
Q1 2023

May 01, 2023

BUY
$16.3 - $19.41 $1.2 Million - $1.43 Million
73,788 Added 34.03%
290,642 $5.64 Million
Q4 2022

Feb 07, 2023

SELL
$14.96 - $17.39 $218,416 - $253,894
-14,600 Reduced 6.31%
216,854 $3.48 Million
Q3 2022

Oct 25, 2022

SELL
$15.68 - $22.27 $5,817 - $8,262
-371 Reduced 0.16%
231,454 $3.63 Million
Q2 2022

Aug 08, 2022

BUY
$17.44 - $23.16 $131,044 - $174,024
7,514 Added 3.35%
231,825 $4.83 Million
Q1 2022

May 06, 2022

SELL
$17.03 - $22.67 $64,731 - $86,168
-3,801 Reduced 1.67%
224,311 $5.09 Million
Q4 2021

Feb 08, 2022

SELL
$15.84 - $21.88 $78,249 - $108,087
-4,940 Reduced 2.12%
228,112 $4.17 Million
Q3 2021

Oct 28, 2021

SELL
$16.3 - $21.14 $8,019 - $10,400
-492 Reduced 0.21%
233,052 $4.93 Million
Q2 2021

Jul 27, 2021

BUY
$17.95 - $25.56 $8,221 - $11,706
458 Added 0.2%
233,544 $4.26 Million
Q1 2021

May 03, 2021

SELL
$20.53 - $25.22 $328,993 - $404,150
-16,025 Reduced 6.43%
233,086 $5.27 Million
Q4 2020

Feb 04, 2021

SELL
$18.39 - $24.8 $931,214 - $1.26 Million
-50,637 Reduced 16.89%
249,111 $5 Million
Q3 2020

Nov 06, 2020

BUY
$20.67 - $26.94 $1.19 Million - $1.55 Million
57,462 Added 23.72%
299,748 $7.33 Million
Q2 2020

Aug 04, 2020

SELL
$16.46 - $27.42 $273,598 - $455,775
-16,622 Reduced 6.42%
242,286 $5.75 Million
Q1 2020

Apr 27, 2020

BUY
$14.46 - $21.8 $738,544 - $1.11 Million
51,075 Added 24.58%
258,908 $4.46 Million
Q4 2019

Feb 03, 2020

BUY
$15.15 - $18.89 $25,209 - $31,432
1,664 Added 0.81%
207,833 $3.66 Million
Q3 2019

Oct 31, 2019

BUY
$17.68 - $22.65 $24,186 - $30,985
1,368 Added 0.67%
206,169 $3.65 Million
Q2 2019

Aug 09, 2019

BUY
$18.93 - $24.75 $19,251 - $25,170
1,017 Added 0.5%
204,801 $4.38 Million
Q1 2019

May 02, 2019

BUY
$19.6 - $24.76 $159,406 - $201,373
8,133 Added 4.16%
203,784 $4.85 Million
Q4 2018

Feb 11, 2019

BUY
$13.65 - $21.8 $110,919 - $177,146
8,126 Added 4.33%
195,651 $3.85 Million
Q3 2018

Oct 22, 2018

BUY
$15.87 - $22.4 $346,854 - $489,574
21,856 Added 13.19%
187,525 $3.32 Million
Q2 2018

Jul 23, 2018

BUY
$18.56 - $22.45 $3.07 Million - $3.72 Million
165,669 New
165,669 $3.57 Million

Others Institutions Holding EXEL

About EXELIXIS, INC.


  • Ticker EXEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 321,832,000
  • Market Cap $11.5B
  • Description
  • Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...
More about EXEL
Track This Portfolio

Track Texas Permanent School Fund Portfolio

Follow Texas Permanent School Fund and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Texas Permanent School Fund, based on Form 13F filings with the SEC.

News

Stay updated on Texas Permanent School Fund with notifications on news.